This observational study will evaluate circulating tumor DNA (ctDNA) as a prognostic marker and as a monitor of disease recurrence in stage III colorectal cancer (CRC).

NIAID Data Ecosystem30

Table_3_PEAC: An Ultrasensitive and Cost-Effective MRD Detection System in Non-small Cell Lung Cancer Using Plasma Specimen.XLSX

非小细胞肺癌MRD检测

液体活检ctDNA

Circulating tumor DNA (ctDNA), a tumor-derived fraction of cell-free DNA (cfDNA), has emerged as a promising marker in targeted therapy, immunotherapy, and minimal residual disease (MRD) monitoring in

NIAID Data Ecosystem100

Triple Negative Breast Cancer RNA Sequencing

三阴性乳腺癌基因组学

癌细胞转录组

We propose to definitively characterise the somatic genetics of triple negative breast cancer through generation of comprehensive catalogues of somatic mutations in breast cancer cases by high coverag

NIAID Data Ecosystem30

CRCQV42Run025-10 - samples

资源简介：

相关数据集